Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,783,113
-
Share change
-
+2,155,975
-
Total reported value
-
$79,003,000
-
Put/Call ratio
-
64%
-
Price per share
-
$2.95
-
Number of holders
-
66
-
Value change
-
+$6,357,683
-
Number of buys
-
34
-
Number of sells
-
18
Institutional Holders of BIODELIVERY SCIENCES INTL IN - COM (BDSI) as of Q4 2017
As of 31 Dec 2017,
BIODELIVERY SCIENCES INTL IN - COM (BDSI) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,783,113 shares.
The largest 10 holders included
Broadfin Capital, LLC, Stonepine Capital Management, LLC, venBio Select Advisor LLC, Vanguard Group Inc, ROYCE & ASSOCIATES LP, BLAIR WILLIAM & CO/IL, AMERIPRISE FINANCIAL INC, BlackRock Inc., Grandeur Peak Global Advisors, LLC, and BANK OF MONTREAL /CAN/.
This page lists
66
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.